Curavit Chosen as Contract Research Organization for MedRhythms Clinical Trial
Company expected to research patient engagement, response durability, and health economics of new medical device.
Curvait Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) for digital therapeutics (DTx), revealed in a company press release that it was chosen for a study of MR-001, MedRhythms' neurorehabilitation system designed to improve walking and ambulation in adults with chronic stroke walking impairments. As part of the collaboration, Curvait will be responsible for managing all aspects of MedRhythms' hybrid decentralized clinical trial (DCT) – from protocol finalization and Institutional Review Board (IRB) approvals to patient recruitment, testing at physical sites, remote site and patient monitoring and healthcare economics and outcomes analysis.
"As innovators in healthcare, it's essential to show that new technologies not only have the power to transform patients' lives but are also economically prudent. Health economics research quantifies the long-term financial impact for patients, providers, and payers," said Owen McCarthy, president, co-founder, MedRhythms. "Curavit's tech-enabled approach to research lets us launch quickly while delivering a premier experience for everyone involved. As important, the study will be open to participants nearly nation-wide, thanks to Curavit's virtual site solution, patient recruitment process, and smart strategies for collecting real-world healthcare economics data."
Reference: MedRhythms Selects Curavit as its Contract Research Organization (CRO) for a Chronic Stroke Decentralized Clinical Trial. PR Newswire. September 20, 2023. Accessed September 25, 2023. https://www.prnewswire.com/news-releases/medrhythms-selects-curavit-as-its-contract-research-organization-cro-for-a-chronic-stroke-decentralized-clinical-trial-301932835.html
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
